Prof. Dr. Dürdane Aksoy

• Multiple Sclerosis 7 publications
  Source: OpenAlex / PubMed MeSHView publications
• Seizures 3 publications
• Sexual Dysfunction, Physiological 2 publications
• Migraine Disorders 2 publications
• Tension-Type Headache 2 publications
• Fatty Liver 2 publications
• Restless Legs Syndrome 2 publications

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicalpark.com.tr.

Experience

• 19941999 Sivas Cumhuriyet Üniversitesi Tıp Fakültesi Nöroloji Ana Bilim Dalımedicalpark.com.tr
• ExperienceEylül-Aralık 1999 Acron General Medical Center Neworadiologymedicalpark.com.tr
• ExperienceTokat Devlet Hastanesimedicalpark.com.tr
• 20112026 Tokat Gaziosmanpaşa Tıp Fakültesi Nöroloji Ana Bilim Dalımedicalpark.com.tr
• Experience2026 Medical Park Tokat Hastanesimedicalpark.com.tr

Education

• 19881994 İstanbul Üniversitesi İstanbul Tıp Fakültesimedicalpark.com.tr

• SpecialtyNeurologymedicalpark.com.trFrom source
• InstitutionMedical Park Tokat Hastanesimedicalpark.com.trFrom source
• Area of workMultiple SclerosisExtracted from 7 publications · Model version —From source
• Publications74 publicationsORCID, OpenAlex, Europe PMCFrom source
• ORCID0000-0003-1981-084XORCIDFrom source
• Last synchronised4 November 2026 20:26https://www.medicalpark.com.tr/hekimler/durdane-aksoymedicalpark.com.tr

1. Effect of laughter yoga on fatigue, sleep quality and psychological well-being in people with multiple sclerosis: A randomized controlled trial

   Multiple Sclerosis and Related Disorders, 2026

   DOI 10.1016/j.msard.2026.107098 PMID 41764939 1 citation (Europe PMC) Source: ORCID

2. Dimethyl fumarate in the treatment of multiple sclerosis: real-world effectiveness in a Turkish cohort

   Frontiers in Neurology, 2026

   DOI 10.3389/fneur.2026.1920500 Open-access full textSource: OpenAlex

3. Exploring the Type 4 Cerebrospinal Fluid Oligoclonal Band Pattern: Clinical and Paraclinical Features with Diagnostic Implications

   Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026

   DOI 10.1007/s10072-026-09383-9 PMID 42711549 Open-access full textSource: Europe PMC

4. Evaluating the risk: Hepatitis B virus reactivation in ocrelizumab-treated patients with multiple sclerosis: A single-center experience and review of the literature

   Multiple Sclerosis and Related Disorders, 2026

   DOI 10.1016/j.msard.2026.107371 PMID 42431141 Source: ORCID

5. Coasting effect of n -hexane-induced neuropathy evidenced by electroneuromyography and clinical symptom scales: a 12-month follow-up study

   Archives of Industrial Hygiene and Toxicology, 2026

   DOI 10.2478/aiht-2026-77-4034 PMID 41944401 1 citation (OpenAlex) Open-access full textSource: OpenAlex

6. Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)

   Journal of Neuroimmunology, 2025

   DOI 10.1016/j.jneuroim.2025.578686 PMID 40694990 3 citations (Europe PMC) Open-access full textSource: ORCID

7. Aile Hekimliğinde Kronik Hastalıkların Yönetimi

   2025

   DOI 10.69860/nobel.9786255542274 Source: ORCID

8. Restless legs syndrome associated with teriflunomide use in two patients with multiple sclerosis

   Clinical Neurology and Neurosurgery, 2025

   DOI 10.1016/j.clineuro.2024.108665 PMID 39616829 Source: ORCID

9. Safety and Efficacy of Cladribine in Patients Discontinuing Fingolimod Due to Elevated Transaminase Levels: The FinClad Study

   Multiple Sclerosis and Related Disorders, 2025

   DOI 10.1016/j.msard.2025.106578 PMID 40570400 1 citation (Europe PMC) Open-access full textSource: ORCID

10. Demographic, Clinical, and Radiological Characteristics of Familial Multiple Sclerosis: A Multicenter Retrospective Study from Turkiye

    Ataturk University - AVESIS, 2025

    Source: OpenAlex